Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Boehringer Ingelheim
US Department of Justice
Merck
Deloitte
Novartis
Citi
Accenture
Fish and Richardson
Fuji

Generated: August 17, 2017

DrugPatentWatch Database Preview

Ranbaxy Company Profile

« Back to Dashboard

What is the competitive landscape for RANBAXY, and when can generic versions of RANBAXY drugs launch?

RANBAXY has fifty-eight approved drugs.

There are five US patents protecting RANBAXY drugs. There are seventeen tentative approvals on RANBAXY drugs.

There are ten patent family members on RANBAXY drugs in eight countries.

Summary for Applicant: Ranbaxy

Patents:5
Tradenames:41
Ingredients:37
NDAs:58
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ranbaxy Labs Ltd
FLUCONAZOLE
fluconazole
TABLET;ORAL076386-003Jul 29, 2004DISCNNoNo► Subscribe► Subscribe► Subscribe
Ranbaxy
HALOG
halcinonide
SOLUTION;TOPICAL017823-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Ranbaxy Labs Ltd
PRAVASTATIN SODIUM
pravastatin sodium
TABLET;ORAL076445-003Apr 23, 2007DISCNNoNo► Subscribe► Subscribe► Subscribe
Ranbaxy
CARBILEV
carbidopa; levodopa
TABLET, FOR SUSPENSION;ORAL076643-003Jun 10, 2005DISCNNoNo► Subscribe► Subscribe► Subscribe
Ranbaxy Labs Ltd
ETODOLAC
etodolac
TABLET;ORAL075226-001Nov 24, 1998DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Ranbaxy

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ranbaxy
LAC-HYDRIN
ammonium lactate
LOTION;TOPICAL019155-001Apr 24, 1985► Subscribe► Subscribe
Ranbaxy
AVENTYL
nortriptyline hydrochloride
SOLUTION;ORAL014685-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Ranbaxy
ULTRAVATE
halobetasol propionate
OINTMENT;TOPICAL019968-001Dec 17, 1990► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for RANBAXY drugs

Drugname Dosage Strength Tradename Submissiondate
isotretinoin
Capsules20 mg
ABSORICA
6/19/2013
isotretinoin
Capsules20 mg
ABSORICA
1/7/2013
isotretinoin
Capsules30 mg and 40 mg
ABSORICA
12/31/2012

International Patent Family for Ranbaxy Drugs

Country Document Number Estimated Expiration
European Patent Office2964195► Subscribe
Austria270544► Subscribe
Canada2423170► Subscribe
World Intellectual Property Organization (WIPO)0224172► Subscribe
Canada2836228► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Ranbaxy Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C/GB98/019United Kingdom► SubscribePRODUCT NAME: A COMBINATION COMPRISING LAMIVUDINE, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, AND ZIDOVUDINE; REGISTERED: UK EU/1/98/058/001 19980318; UK EU/1/98/058/002 19980318
00569Netherlands► SubscribePRODUCT NAME: LINAGLIPTINE, DESGEWENST IN DE VORM VAN EEN ZOUT, IN COMBINATIE MET METFORMINEHYDROCHLORIDE; REGISTRATION NO/DATE: EU/1/12/780/001-028 20120720
C0041Belgium► SubscribePRODUCT NAME: LEVOFLOXACINUM HEMIHYDRICUM; NAT. REGISTRATION NO/DATE: 354 IS 370 F3 19980624; FIRST REGISTRATION: GB 134020011 19970606
2013 00001Denmark► SubscribePRODUCT NAME: 8-(3-AMINOPIPERIDIN-1-YL)-7-BUT-2-INYL-3-METHYL-1-(4-METHYLCHINAZOLIN-2-YLMETHYL)-3,7-DIHYDROPURIN-2,6-DION ENANTIOMERER OG SALTE DERAF - SAERLIGT LINAGLIPTIN - I KOMBINATION MED METFORMINHYDROCHLORID; REG. NO/DATE: EU/1/12/780/001-028 20120720
C0001Belgium► SubscribePRODUCT NAME: FELODIPINUM + RAMIPRILUM; NATL. REGISTRATION NO/DATE: 354 IS 373 F 3 19981103; FIRST REGISTRATION: SE 13597 19970919
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
Fish and Richardson
Baxter
Daiichi Sankyo
Chubb
Medtronic
Citi
Argus Health
QuintilesIMS
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot